OT2-01-01: International Breast Cancer Study Group (IBCSG) Trial 22–00: Low-Dose Cytotoxics as Maintenance “Anti-Angiogenesis Treatment” Following Adjuvant Induction Chemotherapy for Patients with ER-Negative and PgR-Negative Breast Cancer.